ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,381.35
0.33%
Dow Jones
39,387.76
0.85%
Gold vs US Dollar
2,350.00
0.13%
Brent Oil
84.015
0.08%
Bitcoin
62,779.63
-0.43%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. IN8bio Inc (INAB)

  7. IN8bio Inc (INAB) News

IN8bio (INAB)

IN8bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INAB
DateTimeSourceHeadlineSymbolCompany
09/05/202421:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INABIN8bio Inc
09/05/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
09/05/202421:00GlobeNewswire Inc.IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:INABIN8bio Inc
07/05/202421:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INABIN8bio Inc
30/04/202411:05GlobeNewswire Inc.IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed GlioblastomaNASDAQ:INABIN8bio Inc
24/04/202413:00GlobeNewswire Inc.IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual MeetingNASDAQ:INABIN8bio Inc
16/04/202421:05GlobeNewswire Inc.IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:INABIN8bio Inc
09/04/202421:30GlobeNewswire Inc.IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024NASDAQ:INABIN8bio Inc
14/03/202420:00GlobeNewswire Inc.IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business HighlightsNASDAQ:INABIN8bio Inc
05/03/202421:30GlobeNewswire Inc.IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024NASDAQ:INABIN8bio Inc
26/02/202413:00Business WireIN8bio to Present at Upcoming Investor ConferencesNASDAQ:INABIN8bio Inc
14/02/202413:00GlobeNewswire Inc.IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in ImmunologyNASDAQ:INABIN8bio Inc
08/02/202421:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
08/02/202421:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
08/02/202421:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
08/02/202421:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
08/02/202421:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
08/02/202421:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
19/01/202421:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INABIN8bio Inc
19/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INABIN8bio Inc
18/01/202421:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:INABIN8bio Inc
12/01/202422:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INABIN8bio Inc
04/01/202413:00GlobeNewswire Inc.IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline GoalsNASDAQ:INABIN8bio Inc
28/12/202317:28Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:INABIN8bio Inc
15/12/202321:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INABIN8bio Inc
15/12/202313:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
15/12/202313:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
15/12/202313:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
15/12/202313:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
15/12/202313:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
 Showing the most relevant articles for your search:NASDAQ:INAB

Your Recent History

LSE
ITM
Itm Power
LSE
TYM
Tertiary Minerals
LSE
PEN
Pennant
NYSE
SPCE
Virgin Galactic
LSE
AGL
Angle
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved